Cargando…

LncRNA MEG3 Reduces Hippocampal Neuron Apoptosis via the PI3K/AKT/mTOR Pathway in a Rat Model of Temporal Lobe Epilepsy

PURPOSE: Temporal lobe epilepsy (TLE) is a common neurological disorder, which is characterized by recurrent spontaneous seizures. Exploring the mechanisms of epileptogenesis has been considered as a priority. The aim of this study is to investigate the effects of LncRNA MEG3 in spontaneous recurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hongyan, Tao, Jiuyun, Zhang, ShuXia, Lv, XinXin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604460/ https://www.ncbi.nlm.nih.gov/pubmed/33149593 http://dx.doi.org/10.2147/NDT.S270614

Ejemplares similares

LncRNA MEG3 inhibits rheumatoid arthritis through miR‐141 and inactivation of AKT/mTOR signalling pathway
por: Li, Guoqing, et al.
Publicado: (2019)

LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021)

The Association of MEG3 lncRNA with Nuclear Speckles in Living Cells
por: Hasenson, Sarah E., et al.
Publicado: (2022)

Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3
por: Li, Xinyi, et al.
Publicado: (2018)

Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus
por: Zhang, Hailing
Publicado: (2019)

Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children
por: Zhuo, Zhen-Jian, et al.
Publicado: (2018)

Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway
por: Meng, Qian, et al.
Publicado: (2020)

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis
por: Yao, Xinliang, et al.
Publicado: (2018)

LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
por: Wang, Yanhua, et al.
Publicado: (2021)

LncRNA MEG3-TRPV1 signaling regulates chronic inflammatory pain in rats
por: Peng, Jing-Wei, et al.
Publicado: (2022)

Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway
por: Sun, Ruimei, et al.
Publicado: (2019)

Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017)

Modulatory Potential of LncRNA Zfas1 for Inflammation and Neuronal Apoptosis in Temporal Lobe Epilepsy
por: He, Chuan, et al.
Publicado: (2021)

Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy
por: Sha, Long-Ze, et al.
Publicado: (2012)

Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy
por: Pawar, Kamlesh, et al.
Publicado: (2016)

LncRNA Meg3 protects endothelial function by regulating the DNA damage response
por: Shihabudeen Haider Ali, Mohamed Sham, et al.
Publicado: (2019)

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
por: Bayarmaa, Battseren, et al.
Publicado: (2019)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway
por: Uroda, Tina, et al.
Publicado: (2019)

LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway
por: Qi, Fei, et al.
Publicado: (2023)

lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer
por: Zhang, Jingzhou, et al.
Publicado: (2021)

LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy
por: Han, Chun-Lei, et al.
Publicado: (2018)

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
por: Cai, Haiping, et al.
Publicado: (2020)

Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis
por: Gong, Xin, et al.
Publicado: (2020)

Se alleviates homocysteine-induced fibrosis in cardiac fibroblasts via downregulation of lncRNA MEG3
por: Li, Wei, et al.
Publicado: (2021)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

lncRNA MEG3 Suppresses the Progression of Ankylosis Spondylitis by Regulating the Let-7i/SOST Axis
por: Ma, Junjie, et al.
Publicado: (2020)

Expression of lncRNA MEG3 in asthma with different phenotypes and its relationship with course of disease
por: Feng, Yan, et al.
Publicado: (2020)

The lncRNA H19 binding to let‐7b promotes hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy
por: Han, Chun‐Lei, et al.
Publicado: (2020)

Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy
por: Jing, Xu, et al.
Publicado: (2021)

lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration
por: Liu, Wei, et al.
Publicado: (2019)

LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer
por: Meng, Su, et al.
Publicado: (2019)

APOE-mediated suppression of the lncRNA MEG3 protects human cardiovascular cells from chronic inflammation
por: Zhao, Hongkai, et al.
Publicado: (2023)

miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3
por: Wang, Xin-Xing, et al.
Publicado: (2018)

Comparison of temporal lobe epilepsy with hippocampal sclerosis and temporal lobe epilepsies due to other etiologies
por: Asadi-Pooya, Ali A., et al.
Publicado: (2015)

LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy
por: Huang, Xin, et al.
Publicado: (2021)

LncRNA ILF3-AS1 mediated the occurrence of epilepsy through suppressing hippocampal miR-212 expression
por: Cai, Xiaodong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0007ddigdkui77vsfvd45hhuom